ABSI
NASDAQ · Biotechnology
Absci Corp
$5.76
+0.01 (+0.17%)
Open$4.91
Previous Close$5.75
Day High$5.78
Day Low$4.75
52W High$6.24
52W Low$2.24
Volume—
Avg Volume6.08M
Market Cap893.82M
P/E Ratio—
EPS$-0.85
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+308.9% upside
Current
$5.76
$5.76
Target
$23.55
$23.55
$16.79
$23.55 avg
$35.63
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.18M | 4.04M | 58.57M |
| Net Income | -130,675,006 | -149,494,731 | -8,944,093 |
| Profit Margin | -4,113.7% | -3,908.0% | -15.3% |
| EBITDA | -117,034,900 | -141,328,530 | -15,160,350 |
| Free Cash Flow | — | — | -10,726,027 |
| Rev Growth | -21.3% | -21.3% | +10.3% |
| Debt/Equity | 0.00 | 0.00 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |